These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 527638)

  • 21. Disposition of magnolol after intravenous bolus and infusion in rabbits.
    Tsai TH; Chou CJ; Chen CF
    Drug Metab Dispos; 1994; 22(4):518-21. PubMed ID: 7956724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of heparin. II. Studies of time dependence in rats.
    Bjornsson TD; Levy G
    J Pharmacol Exp Ther; 1979 Aug; 210(2):243-6. PubMed ID: 458631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome.
    Hunt CE; Inwood RJ; Shannon DC
    Am Rev Respir Dis; 1979 Feb; 119(2):263-9. PubMed ID: 434598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacokinetics of vindesine infusion.
    Rahmani R; Kleisbauer JP; Cano JP; Martin M; Barbet J
    Cancer Treat Rep; 1985; 69(7-8):839-44. PubMed ID: 2410121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition kinetics of disopyramide in human healthy volunteers described by an open three compartment model.
    Bonde J; Jensen NM; Pedersen LE; Angelo HR; Rasmussen SN; Trap-Jensen J; Kampmann JP
    Pharmacol Toxicol; 1989 May; 64(5):412-6. PubMed ID: 2771866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection.
    Mallo C; Zaĭdan R; Galy G; Vermeulen E; Brun J; Chazot G; Claustrat B
    Eur J Clin Pharmacol; 1990; 38(3):297-301. PubMed ID: 2340850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia.
    Slevin ML; Piall EM; Aherne GW; Johnston A; Sweatman MC; Lister TA
    Br J Clin Pharmacol; 1981 Oct; 12(4):507-10. PubMed ID: 6945865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple method for the administration of doxapram.
    Mattila M; Larma I
    Br J Clin Pharmacol; 1987 Mar; 23(3):371-2. PubMed ID: 3567056
    [No Abstract]   [Full Text] [Related]  

  • 29. Gallamine administered by combined bolus and infusion.
    Shanks CA; Funk DI; Avram MJ; Henthorn TK
    Anesth Analg; 1982 Oct; 61(10):847-52. PubMed ID: 6289700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linear pharmacokinetics of haloperidol in the rat.
    Cheng YF; Paalzow LK
    Biopharm Drug Dispos; 1992 Jan; 13(1):69-76. PubMed ID: 1554878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Re-evaluation of intravenous drip infusion of doxapram--a double-blind method].
    Nishimura N; Fujii S; Chiba T; Zen K; Kusunoki H
    Masui; 1974 Apr; 23(4):328-32. PubMed ID: 4602796
    [No Abstract]   [Full Text] [Related]  

  • 32. Inequality of clearance values obtained by intravenous bolus and by steady-state infusion. Prednisolone studies in dogs.
    Frey FJ; Frey BM
    Pharmacology; 1982; 24(6):346-54. PubMed ID: 7111375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local and systemic tolerability of suprofen. Experience with intravenous administration and infusion in healthy volunteers (2nd comm.).
    Zulliger HW; Michos N; Fenzl E
    Arzneimittelforschung; 1985; 35(4):748-55. PubMed ID: 4015742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiologic effects of doxapram in idiopathic apnea of prematurity.
    Barrington KJ; Finer NN; Peters KL; Barton J
    J Pediatr; 1986 Jan; 108(1):124-9. PubMed ID: 3080569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventilatory response to keto-doxapram in intact and carotid body denervated lambs.
    Bairam A; Canet E; Praud JP; Aranda JV; Bureau MA
    Respir Physiol; 1991 Dec; 86(3):345-54. PubMed ID: 1788494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verapamil disposition kinetics in chronic atrial fibrillation.
    Kates RE; Keefe DL; Schwartz J; Harapat S; Kirsten EB; Harrison DC
    Clin Pharmacol Ther; 1981 Jul; 30(1):44-51. PubMed ID: 7237897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
    Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B
    J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Absorption, excretion and distribution of amikacin following intravenous drip infusion. Intravenous drip infusion, one shot intravenous injection and intramuscular administration of amikacin in dogs, rabbits and rats].
    Matsumoto H; Ochiai K; Nakajima A; Matsuzaki M
    Jpn J Antibiot; 1982 Aug; 35(8):2034-46. PubMed ID: 7154249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of carotid chemoreceptors and ventilation by doxapram in the cat.
    Nishino T; Mokashi A; Lahiri S
    J Appl Physiol Respir Environ Exerc Physiol; 1982 May; 52(5):1261-5. PubMed ID: 7096150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxapram in the treatment of idiopathic apnea of prematurity: desirable dosage and serum concentrations.
    Hayakawa F; Hakamada S; Kuno K; Nakashima T; Miyachi Y
    J Pediatr; 1986 Jul; 109(1):138-40. PubMed ID: 3723234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.